248 related articles for article (PubMed ID: 25213373)
41. Evaluation of mast cells, eosinophils, blood capillaries in oral lichen planus and oral lichenoid mucositis.
Reddy DS; Sivapathasundharam B; Saraswathi TR; SriRam G
Indian J Dent Res; 2012; 23(5):695-6. PubMed ID: 23422629
[TBL] [Abstract][Full Text] [Related]
42. A mechanistic linkage between oral lichen planus and autoimmune thyroid disease.
Robledo-Sierra J; Landin-Wilhelmsen K; Filipsson Nyström H; Eggertsen R; Larsson L; Dafar A; Warfvinge G; Mattsson U; Jontell M
Oral Dis; 2018 Sep; 24(6):1001-1011. PubMed ID: 29500871
[TBL] [Abstract][Full Text] [Related]
43. Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).
McCartan BE; Lamey PJ
J Oral Pathol Med; 1997 Apr; 26(4):176-80. PubMed ID: 9176792
[TBL] [Abstract][Full Text] [Related]
44. Is oral cancer incidence among patients with oral lichen planus/oral lichenoid lesions underestimated?
Gonzalez-Moles MA; Gil-Montoya JA; Ruiz-Avila I; Bravo M
J Oral Pathol Med; 2017 Feb; 46(2):148-153. PubMed ID: 27426232
[TBL] [Abstract][Full Text] [Related]
45. Osteopontin expression in oral lichen planus.
Zhou ZT; Wei BJ; Shi P
J Oral Pathol Med; 2008 Feb; 37(2):94-8. PubMed ID: 18197854
[TBL] [Abstract][Full Text] [Related]
46. Patients with oral erosive and cutaneous lichen planus may have antibodies directed against the chronic ulcerative stomatitis protein antigen of 70-kDa.
Cozzani E; Cacciapuoti M; di Marco E; Zerega B; Descalzi Cancedda F; Parodi A
Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):120-4. PubMed ID: 18853074
[TBL] [Abstract][Full Text] [Related]
47. Significance of antinuclear antibody testing in unexplained second and third trimester fetal deaths.
Incerpi MH; Banks EH; Goodwein SN; Samadi R; Goodwin TM
J Matern Fetal Med; 1998; 7(2):61-4. PubMed ID: 9584815
[TBL] [Abstract][Full Text] [Related]
48. Clinical features of oral lichen planus and oral lichenoid lesions: an oral pathologist's perspective.
Netto JNS; Pires FR; Costa KHA; Fischer RG
Braz Dent J; 2022; 33(3):67-73. PubMed ID: 35766718
[TBL] [Abstract][Full Text] [Related]
49. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
50. Association between serum antinuclear antibody and rheumatoid arthritis.
Liu F; Wang XQ; Zou JW; Li M; Pan CC; Si YQ
Front Immunol; 2024; 15():1358114. PubMed ID: 38711518
[TBL] [Abstract][Full Text] [Related]
51. Different Expression of MicroRNA-146a in Peripheral Blood CD4(+) T Cells and Lesions of Oral Lichen Planus.
Yang JG; Sun YR; Chen GY; Liang XY; Zhang J; Zhou G
Inflammation; 2016 Apr; 39(2):860-6. PubMed ID: 26861135
[TBL] [Abstract][Full Text] [Related]
52. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Sun A; Wang JT; Chia JS; Chiang CP
Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic correlation of oral lichen planus and oral lichenoid lesions: a preliminary study.
Mravak-Stipetić M; Lončar-Brzak B; Bakale-Hodak I; Sabol I; Seiwerth S; Majstorović M; Grce M
ScientificWorldJournal; 2014; 2014():746874. PubMed ID: 25531004
[TBL] [Abstract][Full Text] [Related]
54. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
55. Oral and serum IL-6 levels in oral lichen planus patients.
Gu GM; Martin MD; Darveau RP; Truelove E; Epstein J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):673-8. PubMed ID: 15583539
[TBL] [Abstract][Full Text] [Related]
56. Direct immunofluorescence in oral lichen planus and oral lichenoid reactions.
Raghu AR; Nirmala NR; Sreekumaran N
Quintessence Int; 2002 Mar; 33(3):234-9. PubMed ID: 11921773
[TBL] [Abstract][Full Text] [Related]
57. Possible salivary and serum biomarkers for oral lichen planus.
Totan A; Miricescu D; Parlatescu I; Mohora M; Greabu M
Biotech Histochem; 2015; 90(7):552-8. PubMed ID: 25839238
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical evaluation of Langerhans cells in oral lichen planus and oral lichenoid lesions.
Ferrisse TM; de Oliveira AB; Palaçon MP; da Silveira HA; Massucato EMS; de Almeida LY; Léon JE; Bufalino A
Arch Oral Biol; 2021 Apr; 124():105027. PubMed ID: 33550012
[TBL] [Abstract][Full Text] [Related]
59. Oral lichenoid lesions in HIV-HCV-coinfected subjects during antiviral therapy: 2 cases and review of the literature.
Giuliani M; Lajolo C; Sartorio A; Scivetti M; Capodiferro S; Tumbarello M
Am J Dermatopathol; 2008 Oct; 30(5):466-71. PubMed ID: 18806491
[TBL] [Abstract][Full Text] [Related]
60. Detection of serum antinuclear antibodies in lymphoma patients.
Zou HY; Gu X; Yu WZ; Wang Z; Jiao M
Genet Mol Res; 2015 Dec; 14(4):16546-52. PubMed ID: 26681000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
